| Medical and Health Sciences | Lifetime | 535 | GB 58 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 631 | GB 59 | 99.86 |
| Rheumatology | Lifetime | 18 | GB 3 | 99.90 |
| Clinical Pharmacology | Lifetime | 178 | GB 19 | 99.27 |
| Surgery | Lifetime | 690 | GB 52 | 99.35 |
| Orthopedics and Sports Medicine | Lifetime | 428 | GB 47 | 96.32 |
| Hematology | Lifetime | 733 | GB 64 | 93.47 |
| Rheumatology | 2021-2025 | 13 | GB 2 | 99.67 |
| Surgery | 2021-2025 | 396 | GB 26 | 97.04 |
| Clinical Pharmacology | 2021-2025 | 175 | GB 12 | 93.72 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 980 | GB 66 | 72.54 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 4 | GB 1 | 99.90 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 11 | GB 3 | 99.88 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 17 | GB 3 | 99.89 |
| Inflammatory mediators and NSAID effects | Lifetime | 23 | GB 4 | 99.68 |
| Bone and Joint Diseases | Lifetime | 24 | GB 4 | 99.67 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 35 | GB 4 | 99.65 |
| Systemic Lupus Erythematosus Research | Lifetime | 83 | GB 12 | 99.59 |
| Spondyloarthritis Studies and Treatments | Lifetime | 31 | GB 6 | 99.53 |
| Musculoskeletal pain and rehabilitation | Lifetime | 528 | GB 59 | 98.42 |
| Total Knee Arthroplasty Outcomes | Lifetime | 378 | GB 32 | 98.75 |
| Orthopedic Surgery and Rehabilitation | Lifetime | 613 | GB 34 | 98.01 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 251 | GB 23 | 97.90 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 315 | GB 41 | 97.03 |
| Knee injuries and reconstruction techniques | Lifetime | 511 | GB 30 | 97.62 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 152 | GB 24 | 95.03 |
| Hip disorders and treatments | Lifetime | 546 | GB 48 | 96.64 |
| Lower Extremity Biomechanics and Pathologies | Lifetime | 613 | GB 41 | 96.51 |
| Clinical practice guidelines implementation | Lifetime | 598 | GB 113 | 94.38 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 794 | GB 47 | 88.55 |
| Case Reports on Hematomas | Lifetime | 804 | GB 45 | 69.68 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 550 | GB 25 | 28.64 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 8 | GB 1 | 99.58 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 15 | GB 3 | 99.54 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 6 | GB 1 | 98.50 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 107 | GB 16 | 97.16 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 141 | GB 8 | 93.54 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 126 | GB 13 | 96.15 |
| Total Knee Arthroplasty Outcomes | 2021-2025 | 419 | GB 25 | 95.57 |
| Bone and Joint Diseases | 2021-2025 | 183 | GB 11 | 90.19 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 666 | GB 49 | 91.63 |
| Hip disorders and treatments | 2021-2025 | 327 | GB 10 | 89.48 |
| Knee injuries and reconstruction techniques | 2021-2025 | 556 | GB 29 | 91.65 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 939 | GB 53 | 82.10 |
| Clinical practice guidelines implementation | 2021-2025 | 520 | GB 72 | 75.66 |
| Delphi Technique in Research | 2021-2025 | 655 | GB 172 | 71.41 |
| Healthcare and Venom Research | 2021-2025 | 913 | GB 4 | 50.14 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 691 | GB 87 | 49.05 |